
    
      Single centre, multiple-dose, double-blind, randomised, placebo-controlled, two-way crossover
      study in 12 healthy volunteers. The study consisted of two 8-day treatment periods separated
      by a washout of 10 or more days. During each of the treatment periods the volunteers received
      either a daily oral dose of BIA 2-093 1200 mg once-daily (od) or matching placebo,
      concomitantly with a dose of digoxin (days 1 and 2: loading dose of 0.5 mg/day; days 3 to 8:
      0.25 mg/day).
    
  